免疫检查点免疫疗法免疫疗法的肺毒性
Mohammad I Ghanbar1, Karthik Suresh1,2
1Division of Pulmonary & Critical Care Medicine, Department of Medicine, and.
The Journal of clinical investigation
|January 16, 2024
概括
检查点抑制性肺炎 (CIP) 是癌症免疫治疗的严重肺部副作用. 了解其原因对于开发更好的治疗方法对于这种常见的免疫相关不良事件至关重要.
科学领域:
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 非小细胞肺癌 (NSCLC) 是全球癌症死亡的主要原因.
- 免疫检查点抑制剂 (ICI) 改善了NSCLC治疗结果.
- 免疫相关不良事件 (irAEs) 是ICI的副作用,检查点抑制性肺炎 (CIP) 是一个重大问题.
研究的目的:
- 提供CIP的流行病学和临床特征的全面概述.
- 检查目前对CIP背后的病理生物学的理解.
- 为了突出改善治疗策略的需要,由于有限的治疗选择.
主要方法:
- 对检查点抑制性肺炎现有文献的审查.
- 分析流行病学数据和CIP的临床表现.
- 综合研究CIP发展的免疫机制.
主要成果:
- CIP是一种与ICI治疗相关的常见和严重的irAE.
- 了解CIP的病理生物学是有限的,阻碍了治疗的发展.
- CIP显著影响治疗决策和患者的存活率.
结论:
- 对CIP病理生物学进行进一步的研究对于开发向疗法至关重要.
- 需要改进管理策略,以减轻CIP对NSCLC患者的影响.
- 解决CIP对于优化癌症免疫治疗的好处至关重要.
相关概念视频
Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
Pulmonary Tuberculosis I
243
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
243
Drugs Used in Lower Respiratory Disorders: Overview
445
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
445
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K


